Company Search:
Advanced Search
Sponsored Links
Grindeks AS Company Snapshot
Grindeks AS operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other pharmaceutical manufacturers in Europe: Amarin Corporation PLC of the United Kingdom (2016 sales of £96.76 million [US$133.82 million] of which 100% was Research&Development), Alliance Pharma Plc of the United Kingdom (£97.49 million [US$134.84 million] of which 100% was Pharmaceuticals), and Dottikon ES Holding AG which is based in Switzerland (121.43 million Swiss Francs [US$125.71 million] of which 90% was Pharma Products).

Sales Analysis. During the year ended December of 2016, sales at Grindeks AS were 105.37 million Euro (US$128.34 million). This is an increase of 27.5% versus 2015, when the company's sales were 82.66 million Euro. The sales level in 2016 was fairly close to the level five years ago: in 2011, Grindeks AS had sales of 98.99 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grindeks AS
  Stock Performance Chart for Grindeks AS
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 7.60
(Figures in Euro)
1 Week 5.6%   13 Weeks 11.8%  
4 Weeks -5.1%   52 Weeks 65.9%  
Grindeks AS Key Data:
  Ticker: GRD1R Country: Latvia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 105,366,545
(Year Ending Jan 2017).
Employees: 847
  Currency: Euro Market Cap: 72,846,000
  Fiscal Yr Ends: December Shares Outstanding: 9,585,000
  Share Type: Closely Held Shares: 4,786,750
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.